Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials
Authors:
- 1 October 2012
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 14 (10) , 877-882
Abstract
Objective: Although developed to be a management tool for individuals with diabetes, continuous glucose monitoring (CGM) also has potential value for the assessment of outcomes in clinical studies. We evaluated using CGM as such an outcome measure. Research Design and Methods: Data were analyzed from six previously completed inpatient studies in which both CGM (Freestyle Navigator™ [Abbott Diabetes Care, Alameda, CA] or Guardian® [Medtronic, Northridge, CA]) and reference glucose measurements were available. The analyses included 97 days of data from 93 participants with type 1 diabetes (age range, 5–57 years; mean, 18±12 years). Results: Mean glucose levels per day were similar for the CGM and reference measurements (median, 148 mg/dL vs. 143 mg/dL, respectively; P=0.92), and the correlation of the two was high (r=0.89). Similarly, most glycemia metrics showed no significant differences comparing CGM and reference values, except that the nadir glucose tended to be slightly lower and peak glucose slightly higher with reference measurements than CGM measurements (respective median, 59 mg/dL vs. 66 mg/dL [P=0.05] and 262 mg/dL vs. 257 mg/dL [P=0.003]) and glucose variability as measured with the coefficient of variation was slightly lower with CGM than reference measurements (respective median, 31% vs. 35%; PConclusions: A reasonably high degree of concordance exists when comparing outcomes based on CGM measurements with outcomes based on reference blood glucose measurements. CGM inaccuracy and underestimation of the extremes of hyperglycemia and hypoglycemia can be accounted for in a clinical trial's study design. Thus, in appropriate settings, CGM can be a very meaningful and feasible outcome measure for clinical trials.Keywords
This publication has 15 references indexed in Scilit:
- Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic controlPediatric Critical Care Medicine, 2011
- Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesBMJ, 2011
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 DiabetesDiabetes Care, 2011
- The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 DiabetesDiabetes Care, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- The Accuracy of the Guardian ® RT Continuous Glucose Monitor in Children with Type 1 DiabetesDiabetes Technology & Therapeutics, 2008
- Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose MonitorsDiabetes Care, 2008
- The Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System in Children With Type 1 DiabetesDiabetes Care, 2007
- EditorialPublic Health Genomics, 2000
- The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research GroupDiabetes, 1986